Founder of Chem2Cure, Staff Scientist at the University of Chicago, Ph.D. in Organic Chemistry, drug discovery scientist, synthetic chemist, educator, and advocate for building a modern research culture in Bangladesh.
A founder-led effort to connect global drug discovery practice with the next generation of Bangladeshi chemists and researchers.
Dr. Alam works at the intersection of synthetic organic chemistry, medicinal chemistry, API/process thinking, AI-aided preclinical discovery, and scientific training. Chem2Cure channels that experience into a Bangladesh-focused platform.
Staff Scientist, Center for Chemical Biology and Therapeutics, University of Chicago.
Core contributor to PTC518 (votoplam), now in Phase III trials for Huntington's disease.
Build research-ready chemists who can serve pharma, academia, startups, CROs, and CDMOs.
Advance a next-generation ecosystem for drug discovery, chemistry education, and innovation.
The institute draws from real experience across synthesis, discovery, computational workflows, technical writing, education, and partnership building.
Invite Chem2Cure for training, course partnerships, curriculum design, or research collaboration.
